HIIFS
NVCR icon

Harel Insurance Investments & Financial Services’s NovoCure NVCR Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-888
Closed -$15K – 548
2024
Q2 		$15K Sell
888
-175
-16% -$3.08K ﹤0.01% 458
2024
Q1 		$17K Sell
1,063
-303
-22% -$4.46K ﹤0.01% 455
2023
Q4 		$20K Sell
1,366
-232
-15% -$3.1K ﹤0.01% 496
2023
Q3 		$26K Buy
1,598
+768
+93% +$22.1K ﹤0.01% 526
2023
Q2 		$34K Sell
830
-640
-44% -$39.7K ﹤0.01% 524
2023
Q1 		$88K Buy
1,470
+650
+79% +$51.9K ﹤0.01% 417
2022
Q4 		$60K Sell
820
-120
-13% -$9.03K ﹤0.01% 449
2022
Q3 		$72K Sell
940
-67
-7% -$5.23K ﹤0.01% 455
2022
Q2 		$70K Sell
1,007
-486
-33% -$36.6K ﹤0.01% 455
2022
Q1 		$124K Sell
1,493
-562
-27% -$41.4K ﹤0.01% 429
2021
Q4 		$164K Buy
+2,055
New +$206K ﹤0.01% 440
2020
Q3 		– Sell
-2,000
Closed -$119K – 683
2020
Q2 		$119K Buy
+2,000
New +$132K ﹤0.01% 304

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $652M AUM 36.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harel Insurance Investments & Financial Services's NVCR Position: Q3 2024 in Review

Harel Insurance Investments & Financial Services sold out of NovoCure (NVCR) in Q3 2024, closing a stake of 888 shares — an estimated $15K sold.

Harel Insurance Investments & Financial Services first reported a position in NVCR in Q2 2020 and held it in 12 quarters. The position peaked at $164K in Q4 2021. 225 funds tracked by Wall St. Rank hold NVCR as of Q3 2024.

  • Harel Insurance Investments & Financial Services reported no remaining NovoCure position as of Q3 2024 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 888 NovoCure shares in Q3 2024, an estimated $15K.
  • Harel Insurance Investments & Financial Services first reported a position in NovoCure in Q2 2020 and held it in 12 quarters.
  • Harel Insurance Investments & Financial Services's NovoCure position peaked at $164K in Q4 2021.
  • 225 funds tracked by Wall St. Rank held NovoCure as of Q3 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2024, filed 15 Oct 2024.